WILYY logo

WILYY Demant A/S

Other OTC · Medical - Devices · Healthcare

$23.00
+0.50 (+2.22%)

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hold…

Market Cap: $9.70Bwww.demant.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
120
Aug 12Aug 12

Quote

Day Range
$23.00 – $23.32
52-Week Range
$13.45 – $23.32
Volume
$107.00
Market Cap
$9.70B
50-Day Avg
$20.50
200-Day Avg
$17.28
Prev Close
$22.50
Open
$23.24

Valuation & Ratios

P/E Ratio
29.65
EPS
$3.66
P/B Ratio
4.48
P/S Ratio
1.92
Debt/Equity
2.13
Current Ratio
1.36
Dividend Yield
+0.0%
Gross Margin
+75.6%

Returns & Efficiency

Return on Equity
+15.7%
Return on Assets
+4.0%
FCF Yield
+7.2%
EV/EBITDA
11.87

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$22.97B$1.54B$3.52
2024$22.42B$2.39B$5.45
2023$22.44B$1.79B$4.02
2022$19.70B$2.08B$4.61
2021$17.91B$2.51B$5.35

Social Signal Score

70
5d
70
1 mentions
30d
70
1 mentions
60d
70
1 mentions
90d
70
1 mentions
news: 1

Valuation

Project earnings forward and see what return today's price implies.

Seeded from WILYY's reported EPS growth of -9.9% a year over 4 years.

EPS in 5 years
$2.17
Implied price
$65.12
Return from $23.00
23.1% a year

To earn 15.0% a year on these assumptions you'd need to buy at $32.38 — today's price is already 29.0% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E2025303540
-19.9%0.9%5.6%9.5%12.9%16.0%
-14.9%7.2%12.1%16.3%19.9%23.2%
-9.9%13.5%18.7%23.1%27.0%30.4%
-4.9%19.8%25.3%30.0%34.0%37.7%
0.1%26.2%31.9%36.8%41.1%44.9%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·2d ago·Positive

    Demant A/S (WILYY) Q2 2026 Earnings Call Transcript Demant A/S (WILYY) Q2 2026 Earnings Call Transcript

    View source ↗